Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Two New Kindreds with Complete Factor D Deficiency

Title: Two New Kindreds with Complete Factor D Deficiency
Authors: Puel, Mathilde; Rwayane, Kenza; Vieira Martins, Paula; Chbihi, Marwa; Rieux‐Laucat, Frédéric; Rosain, Jérémie; Jeziorski, Eric; Boisson, Bertrand; Casanova, Jean‐Laurent; Frémeaux‐Bacchi, Véronique; El Sissy, Carine
Source: European Journal of Immunology ; volume 55, issue 3 ; ISSN 0014-2980 1521-4141
Publisher Information: Wiley
Publication Year: 2025
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Inborn deficiencies of the alternative pathway (AP) of the complement system have been associated with life‐threatening infections, mainly by encapsulated bacteria. Complete factor D (FD) deficiencies have been reported in only seven families in the literature. We report two new cases of biochemically and genetically confirmed complete FD deficiency, including the first in a Down syndrome patient. The index cases respectively suffered from severe H. influenza and N. meningitidis infections. Their FD activity was undetectable but was restored by adding recombinant human FD. FD levels were undetectable in the plasma of both patients using ELISA. Genetic analysis of the CFD gene identified a homozygous missense variant p.M40R in one patient, and compound heterozygous variants—a nonsense mutation p.Cys148* and a splice site variant c.212+2T>G—in the other. Patients with Down syndrome are more susceptible to infections, but this case highlights the importance of investigating the complement system, particularly the AP, even in those with Down syndrome or other secondary immune deficiencies. A familial study should follow if a congenital deficiency is found. The natural history of patients with inherited complete FD deficiency underscores the necessity of preventive measures against encapsulated bacteria for those receiving therapeutic MASP‐3 or FD inhibitors.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1002/eji.202451536
Availability: https://doi.org/10.1002/eji.202451536; https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202451536
Rights: http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.F76EFDF5
Database: BASE